Toxicity spectrum of immunotherapy in advanced lung cancer: A safety analysis from clinical trials and a pharmacovigilance system eClinicalMedicine Adverse Events in Clinical Trials Non Clinical Safety Evaluation and Adverse Events in Phase I Trials Pharmacovigilance Population scale identification of differential adverse events before and during a pandemic Nature Computational Science Adverse Event Reporting in Clinical Trials From toxicity assessment to adaptive safety care: implementing comprehensive fast track safety evaluation for anticancer drug development ESMO Open